Peer Review History
| Original SubmissionMay 5, 2020 |
|---|
|
PONE-D-20-13216 Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity PLOS ONE Dear Dr. Thomas, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In your revision you must respond specific to all of the comments of the two reviewers. In particular, the comments about your culturomics methods are mandatory. Further, it is vital that you emphasize the novelty of these data as Reviewer 1 suggests that these data are 'standard' for poultry microbiota studies. Failure respond to these and all of the points made by the reviewers will result in the rejection of the revised manusvript. Please submit your revised manuscript by Jul 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michael H. Kogut, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing. 3. Thank you for stating the following in the Financial Disclosure section: "This work has received, through BIOASTER investment, funding from the French Government through the Investissement d’Avenir program (Grant No. ANR-10-AIRT-03). This study was partially funded by Boehringer Ingelheim Animal Health. Dr Christine Andreoni, who is employed by Boehringer Ingelheim Animal Health, was involved in study design, decision to publish, and preparation of the manuscript." We note that you received funding from a commercial source: Boehringer Ingelheim Animal Health Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is standard manuscript on chicken gut microbiota which does not bring too much of new knowledge but I appreciate that authors did not attempt to overestimate their results. They also tried to combine 16S rRNA sequencing with culturomics. I may argue whether the performance is cause of differences in gut microbiota composition, or vice versa, whether gut microbiota composition in this particular study is the cause for differential performance. Or, whether both factors were mutually independent in this study and simply chickens in different farms have slightly different microbiota composition, and also different farms are of different productivity. In fact, with the design of this study, I would prefer the last possibility, i.e. that everything what was recorded in this study is random, not causal since the farm effect, local environment, humidity, feed storage, litter management, human personnel, ventilation, heating or air conditioning, all of this will be of much greater effect on chicken performance than composition of gut microbiota. However, this is just my opinion and authors may have different. I therefore suggest to check the following minor points. line 49, 55 and throughout rest of the manuscript, you use term „microbiome“. Microbiome should be used to describe genes and genomes of the whole microbial community. However when you preferentially consider viable bacteria, you should use term „microbiota“. Please correct. l. 81 and throughout rest of the manuscript, you use term „16S“. Please use at least „16S rRNA“. This is laboratory slang not suitable for official written document. l.99, you introduce Farm 2 and 3 but reader does not know whether these represent well or poorly performing farms. Please specify this in this place. l.122-124, this is the reason for my concerns. Faecalibacterium is nearly always considered as an indicator of well performing gut. And you report it in poorly performing chickens. And on the other hand, Proteus, E. coli or even Klebsiella, these genera are commonly enriched in poorly performing animals or humans – and you report them as markers of good performance. Let it be, do not correct the text but be careful, this is unusual. l. 144, do not start sentences with numbers. Reword the sentence or use words, three hundreds and forty seven (not the best option in this case). Correct it not only in this position but also in the rest of the manuscript. l. 235, delete „inter-individual“ l. 382, what do you mean by allowed 25% mismatch? That every fourth nucleotide could differ in forward and reverse sequence? This quite a lot. Reviewer #2: The manuscript compares the microbiota of a small subsample of broiler chicks in two high- and one poor-performing barn using culture-independent and culture-dependent methods. Furthermore, antibiosis against Campylobacter jejuni was examined. This is an interesting approach, and the manuscript is generally well written. Following are general and specific comments: General Comments 1. Additional information needs to be provided on the three barns. Why is the performance in the third barn poor? Different source of chicks? Different barn composition? Different husbandry methods? Different stocking densities? What is the cause of the higher mortality? It seems strange that very specific mortality numbers (e.g. two decimal places) are provided for the first two barns, opposed to no decimal points for the poor-performing barn. Also, information on how the birds were chosen should be indicated. More specifically, how was it determined that the chicks chosen are representative of the flock? 2. The connection with C. jejuni needs to be strengthened with justification. In this regard, how was the Campylobacter strain isolated determined to be C. jejuni? Was subspecies characterization of the isolate conducted? Relying on relative frequency of ASVs for Campylobacteriaceae is insufficient. There are multiple species of Campylobacter (≥ 35) along with multiple species of Arcobacter (and other genera), many of which are present in the intestine of birds. At minimum, quantitative PCR for C. jejuni should have been completed. 3. Targeting C. jejuni in chicks needs to be justified. Extensive research has shown that outbreaks of C. jejuni in broiler flocks occurs late in the production cycle. Of the 1000’s of chicks that my team has sampled for C. jejuni, isolation of the bacterium from chicks is very infrequent. Although the mechanisms, are not well understood, presence of maternal antibodies has been suggested as a possible mechanism. The current study is presumably targeting colonization resistance as a mechanism, which is valid, but not handled comprehensively in the manuscript as currently presented. 4. I am uncertain why “bacteriocin” production, or lack thereof of the bacteria from birds from the poor-performing barn was not examined? In this regard, it would have been useful if the authors had included a specific study hypothesis(es) to clarify what was being tested, and what the primary goals/objectives of the study where. The hypothesis presented on L66 is very non-specific, but suggests that colonization resistance was enhanced in the “high-performing barns”. In the introduction, the authors present information on population of the chick intestines by bacteria in caeal digesta and feces (i.e. “Fecal Microbial Transplant”), but the study focuses on bacteriocins specifically (neglecting other mechanisms of colonization resistance). May be a broader scope would have been beneficial. Again, defining the hypothesis/goals of the study would have been beneficial. 5. How do the authors know that the antibiosis was due to bacteriocins and not from other anti-bacterial agents (e.g. secondary metabolites). To confirm bacteriocins, isn’t proof that antibiosis was due to a protein necessary (e.g. loss of action by protease treatment). Given the focus on bacteriocins, more in depth characterization of antibiosis is warranted. 6. The analysis of the culturomics aspect of the study could be strengthened. For example, the application of bioinformatics methodologies would have been beneficial (opposed to the qualitative manner in which the data is presented). To what degree was the diversity of bacteria recovered reflected of diversity of the community (i.e. determined by Illumina sequencing)? The authors should examine recent references in which bioinformatics is applied to culturomics data. The isolation methods applied (e.g. reliance on short-term duration “direct plating” using a relatively limited number of media) would not be expected to recover fastidious taxa. As mentioned above, inclusion of a specific hypothesis would be useful to provide the reader with the goal of the culturomics methods applied. If the goal was to recover diverse obligate anaerobic taxa, this the methods applied are insufficient. 7. The abstract is very generally written, and more specific information on the findings of the study should be included. 8. Some of the information presented in the discussion is beyond the scope of the study. Specific Comments L43. There is no coverage of Campylobacter jejuni in the introduction. See general comments above on the need to include a specific hypothesis(es) and objectives. L88. Is “high performance” farms accurate. The statistics provided suggest that these two barns are comparable to the industry standard. L82. See general comment above on the rationale for targeting the microbiota of 7-day-old chicks when C. jejuni does not typically colonize such young birds in production settings. L93. Why are families italicised but not phyla? L112. Given the current limitations of Illumina sequencing (e.g. targeting one or two variable regions), care should be exercised in resolving ASVs at the genus level of resolution. Typically, relative densities of taxa at the genus and species level should be conducted using an ancillary method such as quantitative PCR. L127. Although I have not personally characterized the caeal microbiota of chicks, the Shannon’s index of diversity seems to be very low (presented in Table 1). In older birds (e.g. 20 days-old), a Shannon’s index in the range of 7 is the norm. This should be handled in the discussion. L130. The higher richness and alpha diversity of the caeal microbiota of chicks from the poor-performing barn is unexpected. This should be handled in the discussion. L135. Inclusion of pair-wise Permanova results should be included (i.e. quantitative evidence for a difference among the three farms). L141. Why only one caecum per farm for culturomics? Why weren’t bacteria recovered from birds on the poor-performing farm (see general comment)? L147. Table 2 is of limited value. The value of including “primary culture” versus “sub-culture” should be clarified. L162. See general comment on quantitative coverage of the culturomics information. L184. Typo (“Bust”). L196. See general comment on validation of bacteriocins. L245. Quantitative PCR for Faecalibacterium and Campylobacter species is necessary to confirm this. L247. This statement (i.e. “usually reported”) is not consistent with the epidemiological data of Campylobacter jejuni outbreaks in broiler barns. See general comment above. This aspect of the discussion must be expanded. L253. This is beyond the scope of the study. L289. See general comment on bacteriocins. L334. See general comment on including additional information on the farms. L353. How were the ten chicks chosen to ensure they were representative of the flock? Was the poor-performing barn consistently so? What was responsible for such high mortality? Was the mortality rates presented in Table 4, 7-day chick mortality, or overall mortality? L381. Additional analyses? Eveness? Permanova? Line 407. Bacilli are class of Firmicutes. Separate treatment of Firmicutes (L411) is confusing. L409. Technically, “dishes” not plates (i.e. Petri dishes). L420. Identification of Campylobacter to species? How done? Other characterization? Strain diversity? See general comment. L445. Near full length L458. How do you know bacterocins, and not other antibacterial compounds. See L473 “putative”? See also general comment above on validation of bacteriocin activity. L464. Why only 26 strains? L474 Why only 32 obligate anaerobes? L465. Why only high-performer chickens? L683. Figure 1 is of limited usefulness. Demote to supplemental. L691. Figure 3 is of limited usefulness given its resolution. There are 35+ species of Campylobacter, multiple species of Arcobacter, and other genera, many of which are common in chickens. Quantitative PCR would have been preferable. See general comment. L693. See general comment regarding resolution of Illumina sequence analysis. L697. As mentioned by the authors, there is extensive inter-bird variation in richness. That the richness is highest at Farm 3 is an interesting observation, and this should be discussed in the discussion section. L700. Why did you choose to use a Bray-Curtis dissimilarity metric? Opposed to UniFrac (differs from dissimilarity measures such as Bray-Curtis dissimilarity in that it incorporates information on the relative relatedness of community members by incorporating phylogenetic distances between observed organisms in the computation)? Statistical analyses among farms should be completed (e.g. pairwise Permanova analysis). L702. Figure 7 was very low resolution and not possible to evaluate as a result. Although generally well written, there are some minor grammatical issues throughout the manuscript that should be corrected. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity PONE-D-20-13216R1 Dear Dr. Thomas, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michael H. Kogut, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-13216R1 Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity Dear Dr. Thomas: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michael H. Kogut Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .